REDDSTAR Shines at the ISCT 2014 Paris Conference
Tuesday, May 27, 2014
Posted by: ISCT Administrator
REDDSTAR Co-ordinator, Professor of Medicine Tim O’Brien NUI Galway, and Orbsen Therapeutics’ Head of Research, Dr. Steve Elliman took part in an interactive workshop during the International Society for Cellular Therapy (ISCT) 20th Anniversary meeting held in France at Le Palais des Congrès de Paris. The workshop showcased ‘EU-funded projects on Cellular Therapies’ and took place on Friday, 24 April 2014 from 15:30- 17:00.
Steve Elliman added, “The 20th ISCT Meeting in Paris featured some outstanding updates in the translational development of cell therapies. I personally enjoyed the Plenary Session of the development of cell therapies for leukaemias and inherited immunodeficiences, which included an inspirational discussion of the challenges and successes of gene-modified cell therapies by Prof. Adrian Thrasher from Great Ormond Street Hospital in the London and Prof. Bruce Levine from University of Pennsylvania. In addition, there was a well-attended and detailed discussion of the development of clinical MSCs for Acute Respiratory Distress Syndrome (ARDS), which was very informative for groups entering the clinical phase of cell therapy testing.”
In response to the EU-funded projects’ workshop and REDDSTAR’s involvement, Massimo Dominici, MD, President of the International Society for Cellular Therapy 2014-16 remarked, ‘The presence of highly valuable speakers representing EU funded research projects represented true added value within our 20th Anniversary Meeting. The feeling I have is that cell therapy in Europe has grown incredibly and, certainly, the EU FP7 granting has provided the proper boost in translating basic concepts into clinical realities for still as yet untreatable diseases. As a global society, ISCT looks forward to showcasing again these EU-based achievements in our future events worldwide”
The REDDSTAR-sponsored session (Workshop 5) was chaired by Dr. Mark Lowdell of the Royal Free and University College Medical School, University College London, UK and Dr. David Gancberg from Directorate Health, Directorate-General for Research and Innovation, European Commission. In addition to Prof. O’ Brien and Dr. Elliman, the workshop also featured Prof. Anne Dickinson, MD, of Newcastle University, UK, a project leader in Celleurope (http://celleurope.eu/) and Dr. Pierre Layrolle, Co-ordinator of Reborne (http://www.reborne.org/) based at INSERM in Toulouse.
For additional information, please contact:
Danielle M. Nicholson
REDDSTAR | Repair of Diabetic Damage by Stromal Cell Administration
1st Floor Orbsen Building
National University of Ireland Galway
Republic of Ireland
t +353 (0)91 528778